Glutamatergic system in bone physiology

In Vivo

Volumn 18, Issue 5, 2004, Pages 621-628

  Kalariti, Niki ^a   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Glutamate; Glutamate receptors; Osteoblasts; Osteoclasts; Review

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID; NEUROTRANSMITTER;

BONE; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HUMAN; INNERVATION; MUSCULOSKELETAL FUNCTION; NERVE FIBER; OSTEOBLAST; OSTEOCLAST; REGULATORY MECHANISM; REVIEW;

EID: 6944238493     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Nedergaard M, Takano T and Hansen AJ: Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 3: 748-755, 2002.
2. Van den Berg CJ and Garfinkel D: A simulation study of brain compartments - metabolism of glutamate and related substances in mouse brain. Biochem J 123: 211-218, 1971.
3. Ottersen OP, Zhang N and Walberg F: Metabolic compartmentation of glutamate and glutamine: morphological evidence obtained by quantitative immunocytochemistry in rat cerebellum. Neuroscience 46: 519-534, 1992.
4. Martinez-Hernandez A, Bell KP and Norenberg MD: Glutamine synthetase: glial localization in brain. Science 195: 1356-1358, 1977.
5. Laake JH, Slyngstad TA, Haug FM and Ottersen OP: Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J Neurochem 65: 871-881, 1995.
6. Skerry TM: Neurotransmitters in Bone. J Musculoskel Neuron Interact 2(5): 401-403, 2002.
7. Collingridge GL and Singer W: Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 11(7): 290-296, 1990.
8. Taylor AF: Functional osteoblastic ionotropic glutamate receptors are a prerequisite for bone formation. J Musculoskel Neuron Interact 2(5): 415-422, 2002.
9. Chenu C: Glutamatergic regulation of bone resorption. J Musculoskel Neuron Interact 2(5): 423-431, 2002.
10. Choi D: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634, 1988.
11. Meldrum B and Garthwaite J: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11(9): 379-387, 1990.
12. Monaghan DT, Bridges RJ and Cotman CW: The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29: 365-402, 1989.
13. Hollmann M and Heinemann S: Cloned glutamate receptors. Annu Rev Neurosci 17: 31-108, 1994.
14. Tanabe Y, Masu M, Ishii T, Shigemoto R and Nakanishi S: A family of metabotropic glutamate receptors. Neuron 8(1): 169-179, 1992.
15. Masu M, Tanabe Y, Tsuchida K, Shigemoto R and Nakanishi S: Sequence and expression of a metabotropic glutamate receptor. Nature 349: 760-765, 1991.
16. Hollmann M, O'Shea-Greenfield A, Rogers SW and Heinemann S: Cloning by functional expression of a member of the glutamate receptor family. Nature 342: 643-648, 1989.
17. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N and Nakanishi S: Molecular cloning and characterization of the rat NMDA receptor. Nature 354: 31-37, 1991.
18. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M and Nakanishi S: Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268: 2836-2843, 1993.
19. Hollmann M: Structure of ionotropic glutamate receptors. In: Handbook of Experimental Pharmacology: Ionotropic Glutamate Receptors in the CNS (Jonas P and Monyer H, eds). Springer-Verlag, Berlin/Heidelberg, 1999, pp 3-98.
20. Rosenmund C, Stern-Bach Y and Stevens CF: The tetrameric structure of a glutamate receptor channel. Science 280: 1596-1599, 1998.
21. Hawkins LM, Chazot PL and Stephensen FA: Biochemical evidence for the co-association of three N-Methyl-D-Aspartate (NMDA) R2 subunits in recombinant NMDA receptors. J Biol Chem 274: 27211-27218, 1999.
22. Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, Yamazaki M, Kumanishi T, Arakawa M, Sakimura K and Mishina M: Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357: 70-74, 1992.
23. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M and Mishina M: Molecular diversity of the NMDA receptor channel. Nature 358: 36-41, 1992.
24. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B and Seeburg PH: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256(5060 1217-1221, 1992.
25. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HS, Lipton SA and Nakanishi N: Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393: 377-381, 1998.
26. Egebjerg J, Bettler B, Hermans-Borgmeyer I and Heinemann S: Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not by AMPA. Nature 351: 745-748, 1991.
27. Keinänen K, Wisden W, Sommer B, Werner P, Herb A, Verdoorn TA, Sakmann B and Seeburg PH: A family of AMPA selective glutamate receptors. Science 249(4968): 556-560, 1990.
28. Pin JP and Duvoisin R: The metabotropic glutamate receptors: structure, functions. Neuropharmacology 34: 1-26, 1995.
29. Smart TG: Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr Opin Neurobiol 7: 358-367, 1997.
30. Niethammer M, Kim E and Sheng M: Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J Neurosci 16: 2157-2163, 1996.
31. Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF and Huganir RL: GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386: 279-284, 1997.
32. Kornau HC, Schenker LT, Kennedy MB and Seeburg PH: Domain interaction between NMDA receptor subunits and the postsynaptic density protein PDS-95. Science 269: 1737-1740, 1995.
33. Garthwaite J: Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 14: 60-67, 1991.
34. Wyszynski M, Lin J, Rao A, Nigh E, Beggs AH, Craig AM and Sheng M: Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature 385: 439-442, 1997.
35. Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL and Worley PF: Homer: a protein that selectively binds metabotropic glutamate receptors, Nature 386: 284-288, 1997.
36. Yu XM, Askalan R, Keil GJ and Salter MW: NMDA channel regulation by channel associated protein tyrosine kinase Src. Science 275: 674-678, 1997.
37. Slotboom DJ, Konings WN and Lolkema JS: Structural features of the glutamate transporter family. Microbiol Mol Biol Rev 63: 293-307, 1999.
38. Stoffel W, Sasse J, Duker M, Muller R, Hofmann K, Fink T and Lichter P: Human high affinity, Na-dependent L-glutamate/L-aspartate transporter GLAST-1 (EAAT-1): gene structure and localization to chromosome 5p11-p12. FEBS Lett 386: 189-193, 1996.
39. Finan TM, Oresnik I and Bottacin A: Mutants of Rhizobium melitoti defective in succinate metabolism. J Bacteriol 170: 3396-3403, 1988.
40. Finan TM, Wood JM and Jordan DC: Succinate transport in Rhizobium leguminosarum. J Bacteriol 148: 193-202, 1981.
41. Arriza JL, Kavanaugh MP, Fairman WA, Wu YN, Murdoch GH, North RA and Amara SG: Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J Biol Chem 268: 15329-15332, 1993.
42. Kekuda R, Prasad PD, Fei YJ, Torres-Zamorano V, Sinha S, Yang-Feng TL, Leibach FH and Ganapathy V: Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line. J Biol Chem 271: 18657-18661, 1996.
43. (+)-dependent neutral amino acid transporter BO. Am J Physiol 272: G1463-1472, 1997.
44. +-dependent neutral amino acid transporter. J Biol Chem 271: 14883-14890, 1996.
45. (+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89: 10955-10959, 1992.
46. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E and Kanner BI: Cloning and expression of a rat brain L-glutamate transporter. Nature 360: 464-467, 1992.
47. Kanai Y and Hediger MA: Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360 467-471, 1992.
48. Tanaka K: Cloning and expression of a glutamate transporter from mouse brain. Neurosci Lett 159: 183-186, 1993.
49. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP and Amara SG: An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375: 599-603, 1995.
50. Arriza JL, Eliasof S, Kavanaugh MP and Amara SG: Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 8: 4155-4160, 1997.
51. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N and Kuncl RW: Localization of neuronal and glial glutamate transporters. Neuron 13: 713-725, 1994.
52. Seal RP and Amara SG: A reentrant loop domain in the glutamate carrier EAAT1 participates in substrate binding and translocation. Neuron 21: 1487-1498, 1998.
53. Yoneda Y and Ogita K: Localization of 3H glutamate binding-sites in rat adrenal-medulla. Brain Res 383: 387-391, 1986.
54. Shannon HE and Sawyer BD: Glutamate receptors of the NMDA subtype in the myenteric plexus of the guinea-pig ileum. J Pharmacol Exp Ther 251: 518-523, 1989.
55. Said SI, Berisha HI and Pakbaz H: Excitotoxicity in the lung NMDA induced, nitric oxide-dependent, pulmonary-edema is attenuated by VIP and by inhibitors of poly(adp-ribose) polymerase. Proc Natl Acad Sci USA 93: 4688-4692, 1996.
56. Inagaki N, Kuromi H, Gonoi T, Okamoto Y, Ishida H, Seino Y, Kaneko T, Iwanaga T and Seino S: Expression and role of ionotropic glutamate receptors in pancreatic-islet cells. FASEB J 9: 686-691, 1995.
57. Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA and Skerry TM: Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone 20: 199-205, 1997.
58. Skerry TM and Genever PG: Glutamate signalling in nonneuronal tissues. Trends Pharmacol Sci 22: 174-181, 2001.
59. Peet NM, Grabowski PS, Laketic LI and Skerry TM: The glutamate receptor antagonist MK801 modulates bone resorption by a mechanism predominantly involving osteoclast differentiation. FASEB J 13: 2179-2185, 1999.
60. Noda M and Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor- beta. Endocrinology 124: 2991-2994, 1989.
61. Akatsu T, Takahashi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N and Suda T: Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 6: 183-189, 1991.
62. Marusic A, Kalinowski JF, Harrison JR, Centrella M, Raisz LG and Lorenzo JA: Effects of transforming growth factor-beta and IL-1 alpha on prostaglandin synthesis in serum-deprived osteoblastic cells. J Immunol 146: 2633-2638, 1991.
63. McCarthy TL, Centrella M, Raisz LG and Canalis E: Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 128 2895-2900, 1991.
64. Ralston SH, Todd D, Helfrich MH, Benjamin N and Grabowski P: Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135: 330-336, 1994.
65. Kanematsu M, Ikeda K and Yamada Y: Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells. J Bone Miner Res 12: 1789-1796, 1997.
66. Ajubi NE, Klein-Nulend J, Alblas MJ, Burger EH and Nijweide PJ: Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. Am J Physiol 276: E171-178, 1999.
67. Bhangu PS, Genever PG, Spencer GJ, Grewal TS and Skerry TM: SU190: Mechanisms for regulate uptake and release of glutamate by osteoblasts. J Bone Miner Res S1: S378, 2000.
68. Genever PG and Skerry TM: O-30: Regulated glutamate exocytosis in osteoblasts. Calcif Tissue Int S1: S57, 2000b.
69. Genever PG and Skerry TM: SU191: Regulated glutamate exocytosis is necessary for osteoblast differentiation and survival in vitro. J Bone Miner Res S1: S378, 2000c.
70. Genever PG, Grewal TS, Bhangu PS, Preston MR, Gu Y, Publicover SJ and Skerry TM: O-18: Focal glutamate signalling in osteoblasts by regulated vesicular exocytosis. Calcif Tissue Int S1 S41, 1999.
71. Taylor AF: Osteoblastic glutamate receptor function regulates bone formation and resorption. J Musculoskel Neuron Interact 2(3): 285-290, 2002.
72. Gu Y and Publicover SJ: Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts. J Biol Chem 275; 44(3): 34252-34259, 2000.
73. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D and Skerry TM: Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 25: 631-637, 1999.
74. Itzstein C, Cheynel H, Burt-Pichat B, Merle B, Espinosa L, Delmas PD and Chenu C: Molecular identification of NMDA glutamate receptors expressed in bone cells. J Cell Biochem 82: 134-144, 2001.
75. Patton AJ, Genever PG, Birch MA, Suva LJ and Skerry TM: Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 22(6): 645-649, 1998.
76. Hinoi E, Fujimori S, Nakamura Y and Yoneda Y: Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. Biochem Biophys Res Commun 281: 341-346, 2001.
77. Mason DJ and Hugget JF: Glutamate transporters in bone. J Musculoskel Neuron Interact 2(5): 406-414, 2002.
78. Skerry TM: Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: the role of glutamate as a paracrine signaling agent in the skeleton. J Bone Miner Metab 17: 66-70, 1999.
79. Birch MA, Genever PG, Laketic-Ljubojevic I, Patton AJ, Peet NM and Skerry TM: Glutamate receptor activation is necessary for bone formation in vitro. J Bone Miner Res 12: 10,1997.
80. Pizzi M, Boroni F, Moraitis K, Bianchetti A, Memo M and Spano P: Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression. Eur J Neurosci 11: 2489-2496, 1999.
81. Civitelli R, Reid IR, Westbrook S, Avioli LV and Hruska KA: PTH elevates inositol polyphosphates and diacylglycerol in a rat osteoblast-like cell line. Am J Physiol 255: E660-667, 1988.
82. Schwindinger WF, Fredricks J, Watkins L, Robinson H, Bathon JM, Pines M, Suva LJ and Levine MA: Coupling of the PTH/PTHrP receptor to multiple G-proteins. Direct demonstration of receptor activation of Gs, Gq/11, and Gi(1) by [alpha-32P]GTP-gamma-azidoanilide photoaffinity labeling. Endocrine 8: 201-209, 1998.
83. Hinoi E, Fujimori S and Yoneda Y: Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. Faseb 17: 1532-1534, 2003.
84. Chenu C, Serre CM, Raynal C, Burt-Pichat B and Delmas PD: Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22: 295-299, 1998.
85. Itzstein C, Espinosa L, Delmas PD and Chenu C: Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption. Biochem Biophys Res Commun 268: 201-209, 2000.
86. Kohr G and Seeburg PH: Subtype-specific regulation of recombinant NMDA receptor channels by protein tyrosine kinases of the Src family. J Physiol 492: 445-452, 1996.
87. Boyce BF, Yoneda T, Lowe C, Soriano P and Mundy GR: Requirement of pp60c-Src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90: 1622-1627, 1992.